Preliminary results from a coronavirus vaccine trial involving more than 1,000 people in the UK suggest it is safe and induces an immune response
Preliminary results of a Phase 1/2 trial of a coronavirus vaccine developed by the University of Oxford suggest that it is safe and induces an immune response.
The trial included 1,077 people age 18 to 55 with no history of Covid-19 and took place in five UK hospitals from late April to late May. Participants received the Covid-19 vaccine or the meningococcal conjugate vaccine, as a control group. “However, we need more research before we can confirm the vaccine effectively protects against SARS-CoV-2 infection, and for how long any protection lasts,” the statement added.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Promising Sign As Coronavirus Vaccine Developed By AstraZeneca And Oxford University Appears Safe, Early Trials ShowThe vaccine is still in early-stage clinical trials, and it is yet to be seen whether it can protect people against the virus.
Read more »
Oxford University, AstraZeneca Covid-19 Vaccine Front-Runner Shows Promise in TrialsA leading coronavirus-vaccine candidate being developed by University of Oxford researchers and AstraZeneca showed positive results in early trials, according to published results, raising the prospect that a shot could be available by the end of this year.
Read more »
Coronavirus vaccine from Oxford and AstraZeneca shows positive response in early trialA potential coronavirus vaccine developed by Oxford University in the U.K. has produced an immune response in an early-stage human trial, according to newly released data published Monday in medical journal The Lancet.
Read more »
Oxford coronavirus vaccine generates promising Phase 1/2 results: StudyA team of scientists at the University of Oxford released promising results showing their COVID-19 vaccine appears safe in an early-stage study — welcome news for one of the most advanced vaccine programs in the world. The Phase 1/2 results, published Monday in the scientific journal The Lancet, also
Read more »
Oxford coronavirus vaccine generates promising Phase 1/2 results: Study
Read more »
Oxford vaccine trial shows ‘double immunity’ against COVID-19Oxford University released the results of its phase 1 trial, and found the vaccine creates double immunity antibody cells. They are now ready to move forward with more aggressive testing, including clinical trials in the United States.
Read more »